Record 053 · Therapeutics · 2019
50%19.53.X
Loyal
Loyal
“The first serious drug company for canine longevity — a regulatory path with a shorter life.”
Loyal is taking lifespan drugs for dogs through the FDA’s animal pathway. If it works, the dog is the proof, then the human question follows.
A therapeutics regulatory hack that is also a product.
Series B+. Filed from the Top Tier Impact landscape.
- Canine longevity drugs
- FDA animal pathway
Longer good years for the dog.
